G Di Colo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G Di Colo

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

International Journal of Pharmaceutics|March 16, 2001

Gel-forming erodible inserts for ocular controlled delivery of ofloxacinG Di Colo, S Burgalassi, P Chetoni, et al.

International Journal of Pharmaceutics|May 30, 2001

Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly(ethylene oxide)G Di Colo, S Burgalassi, P Chetoni, et al.

Clinical and Experimental Immunology|March 19, 2011

Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodiesF Pratesi, C Tommasi, C Anzilotti, et al.

Clinical Rheumatology|January 31, 2014

Two Takayasu arteritis patients successfully treated with rituximabE Caltran, G Di Colo, G Ghigliotti, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

International Journal of Pharmaceutics|March 16, 2001

Gel-forming erodible inserts for ocular controlled delivery of ofloxacinG Di Colo, S Burgalassi, P Chetoni, et al.

International Journal of Pharmaceutics|May 30, 2001

Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly(ethylene oxide)G Di Colo, S Burgalassi, P Chetoni, et al.

Clinical and Experimental Immunology|March 19, 2011

Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodiesF Pratesi, C Tommasi, C Anzilotti, et al.

Clinical Rheumatology|January 31, 2014

Two Takayasu arteritis patients successfully treated with rituximabE Caltran, G Di Colo, G Ghigliotti, et al.

Pageof 4